Aurobindo receives FDA approval for lacosamide tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application lacosamide tablets USP, 50mg, 100mg, 150mg, and 200mg.